• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Transcatheter aortic valve ‐in‐valve treatment of degenerative stentless supra‐annular Freedom Solo valves: A single centre experience
ConclusionsViV‐TAVI in stentless Freedom Solo valves is high risk. The risk of coronary occlusion is high. The smallest possible prosthesis (1:1 sizing) should be used, and strategies to protect the coronary vessels must be considered. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - June 16, 2016 Category: Cardiovascular & Thoracic Surgery Authors: James Cockburn, Maureen Dooley, Jessica Parker, Andrew Hill, Nevil Hutchinson, Adam de Belder, Uday Trivedi, David Hildick ‐Smith Tags: Valvular and Structural Heart Diseases Source Type: research

Transcatheter valve ‐in‐ring implantation of a repositionable valve system for treatment of severe mitral regurgitation
ConclusionTransapical valve‐in‐ring implantation of the repositionable Lotus valve system in the mitral position is a feasible and promising option that merits further evaluation. © 2015 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 22, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Michael Lauterbach, Bruno Sontag, Alexandros Paraforos, Ivar Friedrich, Karl ‐Eugen Hauptmann Tags: E ‐Only: Valvular and Structural Heart Diseases Source Type: research

Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis
ConclusionsIn a “real world” registry, ACT compared favorably against the well‐studied SXT and MCV devices in both safety and efficacy. MCV implantation was associated with lower device success rates and higher rates of new permanent pacemaker implantation. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 27, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Tannas Jatene, Antonio Castro ‐Filho, Rafael A. Meneguz‐Moreno, Dimytri A. Siqueira, Alexandre A.C. Abizaid, Auristela I.O. Ramos, Magaly Arrais, David C.S. Le Bihan, Rodrigo B.M. Barretto, Adriana C. Moreira, Amanda G.M.R. Sousa, J. Eduardo Sousa Tags: Valvular and Structural Heart Diseases Source Type: research

Procedural and 30 ‐day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study
ConclusionsRELEVANT study showed that TAVR using Lotus, in a real‐world population of patients with severe aortic stenosis at high surgical risk, was associated with excellent device success implantation and early safety according to VARC‐2 definition. The pacemaker implantation rate was about a third of patients. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - January 31, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Rocco A. Montone, Luca Testa, Chiara Fraccaro, Matteo Montorfano, Fausto Castriota, Roberto Nerla, Marco Angelillis, Maurizio Tusa, Francesco Giannini, Andrea Garatti, Giuseppe Tarantini, Anna Sonia Petronio, Nedy Brambilla, Francesco Bedogni Tags: Valvular and Structural Heart Diseases Source Type: research

Thrombotic valvular dysfunction with transcatheter mitral interventions for postsurgical failures
ConclusionThrombotic related dysfunction post‐TMVR occurred in 15% (2/13) of patients and one patient had abnormal leaflet thickening that may have been thrombus related. Dual‐antiplatelet therapy was used in all 3 cases suggesting the possible need for oral anticoagulation postmitral valve‐in‐valve therapy. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 9, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Marvin H. Eng, Adam Greenbaum, Dee Dee Wang, Janet Wyman, DNP, Heider Arjomand, Pradeep Yadav, Hassan Nemeh, Gaetano Paone, Mayra Guerrero, William O'Neill Tags: Valvular and Structural Heart Diseases Source Type: research

End ‐stage renal disease and severe aortic stenosis: Does valve replacement improve one‐year outcomes?
ConclusionsPatients with ESRD and severe AS have a similar and higher survival with TAVR or SAVR when compared to BAV at 1‐year. These results may influence patient care decisions favoring valve replacement in AS patients with ESRD. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 16, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Jose F. Condado, Aneel Maini, Bradley Leshnower, Vinod Thourani, Jessica Forcillo, Chandan Devireddy, Kreton Mavromatis, Eric L. Sarin, James Stewart, Robert Guyton, Amy Simone, Patricia Keegan, Stamatios Lerakis, Peter C. Block, Vasilis Babaliaros Tags: Valvular and Structural Heart Diseases Source Type: research

Outcome of implantation of a second self ‐expanding valve for the treatment of residual significant aortic regurgitation
ConclusionsSecond implantation of self‐expanding valve can successfully reduce residual significant AR following initial CV implantation and should be considered as therapeutic option for this population. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Edward Koifman, Nirav Patel, Gaby Weissman, Sarkis Kiramijyan, Romain Didier, Rebecca Torguson, Sandeep Kumar, Arpi Tavil ‐Shatelyan, Itsik Ben‐Dor, Lowell F. Satler, Augusto D. Pichard, Ron Waksman Tags: Valvular and Structural Heart Diseases Source Type: research

Transcatheter versus surgical aortic valve replacement in intermediate ‐risk patients: Evidence from a meta‐analysis
ConclusionsOur analysis of mid‐term results showed that TAVR has similar clinical efficacy to SAVR in intermediate‐risk patients with severe AS, and can be a suitable alternative to surgical valve replacement. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - April 11, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Partha Sardar, Amartya Kundu, Saurav Chatterjee, Dmitriy N. Feldman, Theophilus Owan, Nikolaos Kakouros, Ramez Nairooz, Linda A. Pape, Ted Feldman, J. Dawn Abbott, Sammy Elmariah Tags: Valvular and Structural Heart Diseases Source Type: research

Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta ‐analysis
ConclusionOur meta‐analysis suggests that use of LA for TAVR is associated with a lower 30‐day mortality, shorter procedure time, fluoroscopy time, ICU LOS, hospital length of stay, and reduced need for inotropic support.
Source: Catheterization and Cardiovascular Interventions - July 24, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Pedro A. Villablanca, Divyanshu Mohananey, Katarina Nikolic, Sripal Bangalore, David P. Slovut, Verghese Mathew, Vinod H. Thourani, Josep Rode's ‐Cabau, Iván J. Núñez‐Gil, Tina Shah, Tanush Gupta, David F. Briceno, Mario J. Garcia, Jacob T Gutsche, Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis
ConclusionsThere was no significant difference in the utilization rates, in‐hospital outcomes, and cost of TAVR between Caucasians and AA patients in contemporary US practice. Further comparative studies of surgical and TAVR in AAs and other racial minorities are warranted.
Source: Catheterization and Cardiovascular Interventions - September 23, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Fahad Alqahtani, Sami Aljohani, Ahmad Almustafa, Mohammed Alhijji, Oluseun Ali, David R. Holmes, Mohamad Alkhouli Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement
ConclusionsIn patients undergoing TAVR, low flow was an independent predictor of 1‐year mortality and HF, and a stronger predictor than either low AVG or LVEF. Patients with low flow and preserved EF had increased mortality and HF at 1‐year, while those with low flow and reduced EF had outcomes similar to patients with normal flow.
Source: Catheterization and Cardiovascular Interventions - October 8, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Edward T. Carreras, Tsuyoshi Kaneko, Fernando Ramirez ‐Del Val, Marc P. Pelletier, Piotr S. Sobieszczyk, Deepak L. Bhatt, Pinak B. Shah Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta ‐analysis of randomized trials and propensity score matched observational studies
ConclusionsIn patients who are at low surgical risk, TAVR seems to be associated with increased mortality risk. Until more data in this population is available, SAVR should remain the treatment of choice for these patients.
Source: Catheterization and Cardiovascular Interventions - February 1, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Guy Witberg, Adi Lador, Dafna Yahav, Ran Kornowski Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Supra ‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
ConclusionsA supra‐annular structure based sizing strategy is feasible for TAVR in patients with bicuspid AS.
Source: Catheterization and Cardiovascular Interventions - February 5, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Xianbao Liu, Yuxin He, Qifeng Zhu, Feng Gao, Wei He, Lei Yu, Qijing Zhou, Minjian Kong, Jian'an Wang Tags: ORIGINAL STUDIES Source Type: research

In ‐hospital outcomes of transcatheter versus surgical aortic valve replacement in non‐teaching hospitals
ConclusionsTAVR conferred similar in ‐hospital mortality and major peri‐procedural complications compared with SAVR in non‐teaching hospitals. For those with limited access to teaching hospitals, non‐teaching hospitals appear to be a reasonable option for candidates of aortic valve replacement for severe aortic stenosis.
Source: Catheterization and Cardiovascular Interventions - November 8, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Tomo Ando, Oluwole Adegbala, Pedro A. Villablanca, Alexandros Briasoulis, Hisato Takagi, Cindy L. Grines, Theodore Schreiber, Tamim Nazif, Susheel Kodali, Luis Afonso Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Pages: 1  2  3